4//SEC Filing
Holmes Scott A 4
Accession 0001114220-18-000094
CIK 0001114220other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 7:11 AM ET
Size
5.0 KB
Accession
0001114220-18-000094
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-08-15$3.04/sh−1,185$3,602→ 165,365 total
Footnotes (2)
- [F1]Sale of a total of 1,185 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 4,063 shares of restricted stock on August 14, 2018. Mr. Holmes had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 74,581 shares of restricted stock.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeother
Related Parties
1- filerCIK 0001537670
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 7:11 AM ET
- Size
- 5.0 KB